WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018104879) COMPOSITION FOR THE TREATMENT OF OSTEOARTHRITIS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/104879    International Application No.:    PCT/IB2017/057685
Publication Date: 14.06.2018 International Filing Date: 06.12.2017
IPC:
A61K 31/663 (2006.01), A61P 19/02 (2006.01), A61K 9/00 (2006.01), A61K 9/19 (2006.01), A61M 5/178 (2006.01)
Applicants: ABIOGEN PHARMA S.P.A. [IT/IT]; Via Meucci, 36 Loc. Ospedaletto 56121 Pisa (IT)
Inventors: NEGGIANI, Fabio; (IT).
TRASCIATTI, Silvia; (IT)
Agent: CATTANEO, Elisabetta; (IT).
GERVASI, Gemma; (IT).
PALLINI GERVASI, Diego; (IT).
COPPO, Alessandro; (IT).
ZACCARO, Elisabetta; (IT).
PALLADINO, Massimo; (IT).
BRIGHENTI, Livio; (IT).
VALENZA, Silvia; (IT).
CELONA, Antonio; (IT).
DE BORTOLI, Tiziano; (IT).
SAVI, Massimiliano; (IT).
TORTI, Carlo Maria Emilio; (IT).
CINQUANTINI, Bruno; (IT).
CONTADIN, Giorgio; (IT)
Priority Data:
102016000123773 06.12.2016 IT
Title (EN) COMPOSITION FOR THE TREATMENT OF OSTEOARTHRITIS
(FR) COMPOSITION POUR LE TRAITEMENT DE L’ARTHROSE
Abstract: front page image
(EN)The present invention relates to a composition for use in the treatment of osteoarthritis (OA), wherein said composition comprises from 5 to 40 mg of sodium chlodronate, or an equivalent amount of chlodronic acid, or other pharmaceutically acceptable salts thereof, and wherein said composition is administered intra- articularly in a unitary dosage form once monthly, once biweekly or once weekly. Single-dose medicaments and kits comprising them are also described.
(FR)La présente invention concerne une composition pour utilisation dans le traitement de l’arthrose (OA), ladite composition comprenant de 5 à 40 mg de chlodronate de sodium, ou une quantité équivalente d’acide chlodronique, ou d’autres sels pharmaceutiquement acceptables de celui-ci, et ladite composition étant administrée de manière intra-articulaire dans une forme pharmaceutique unitaire une fois par mois, une fois toutes les deux semaine ou une fois par semaine. L’invention concerne en outre des médicaments à dose unique et des trousses comprenant ceux-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: Italian (IT)